Table of Contents Author Guidelines Submit a Manuscript
Enzyme Research
Volume 2016, Article ID 9526593, 6 pages
http://dx.doi.org/10.1155/2016/9526593
Research Article

Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus

1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
2Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
3Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran

Received 14 June 2016; Revised 14 August 2016; Accepted 1 November 2016

Academic Editor: Ali-Akbar Saboury

Copyright © 2016 Bagher Larijani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. M. Goodrich, S. K. Crowley, D.-C. Lee, X. S. Sui, S. P. Hooker, and S. N. Blair, “Associations of cardiorespiratory fitness and parental history of diabetes with risk of type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 95, no. 3, pp. 425–431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Czupryniak, “Guidelines for the management of type 2 diabetes: is ADA and EASD consensus more clinically relevant than the IDF recommendations?” Diabetes Research and Clinical Practice, vol. 86, no. 1, pp. S22–S25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. S. Prakash, S. Chennaiah, Y. S. R. Murthy, E. Anjaiah, S. Ananda Rao, and C. Suresh, “Altered adenosine deaminase activity in type 2 diabetes mellitus,” Journal, Indian Academy of Clinical Medicine, vol. 7, no. 2, pp. 114–117, 2006. View at Google Scholar · View at Scopus
  4. J. M. Aran, D. Colomer, E. Matutes, J. L. Vives-Corrons, and R. Franco, “Presence of adenosine deaminase on the surface of mononuclear blood cells: immunochemical localization using light and electron microscopy,” Journal of Histochemistry and Cytochemistry, vol. 39, no. 8, pp. 1001–1008, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Franco, J. M. Aran, D. Colomer, E. Matutes, and J. L. Vives-Corrons, “Association of adenosine deaminase with erythrocyte and platelet plasma membrane: an immunological study using light and electron microscopy,” Journal of Histochemistry and Cytochemistry, vol. 38, no. 5, pp. 653–658, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. J. Ngerer, S. H. Oosthulzeu, S. H. Bissbort, and W. J. Wermaak, “Serum adenosine deaminase: isoenzymes and diagnostic application,” Clinical Chemistry, vol. 38, no. 7, pp. 1322–1326, 1992. View at Google Scholar
  7. M. Gupta and V. Nair, “Adenosine deaminase in nucleoside synthesis. A review,” Collection of Czechoslovak Chemical Communications, vol. 71, no. 6, pp. 769–787, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. V. Zavialov, X. Yu, D. Spillmann, G. Lauvau, and A. V. Zavialo, “Structural basis for the growth factor activity of human adenosine deaminase ADA2,” Journal of Biological Chemistry, vol. 285, no. 16, pp. 12367–12377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. V. Zavialov and Å. Engström, “Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity,” Biochemical Journal, vol. 391, no. 1, pp. 51–57, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Iijima, T. Kunieda, S. Yamaguchi et al., “The extracellular adenosine deaminase growth factor, ADGF/CECR1, plays a role in Xenopus embryogenesis via the adenosine/P1 receptor,” The Journal of Biological Chemistry, vol. 283, no. 4, pp. 2255–2264, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Kameoka, T. Tanaka, Y. Nojima, S. F. Schlossman, and C. Morimoto, “Direct association of adenosine deaminase with a T cell activation antigen, CD26,” Science, vol. 261, no. 5120, pp. 466–469, 1993. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Gracia, K. Pérez-Capote, E. Moreno et al., “A2A adenosine receptor ligand binding and signalling is allosterically modulated by adenosine deaminase,” Biochemical Journal, vol. 435, no. 3, pp. 701–709, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. D. J. Drucker, “Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes,” Diabetes Care, vol. 30, no. 6, pp. 1335–1343, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Wu and E. B. Marliss, “Deficiency of purine nucleoside phosphorylase activity in thymocytes from the immunodeficient diabetic BB rat,” Clinical and Experimental Immunology, vol. 86, no. 2, pp. 260–265, 1991. View at Google Scholar · View at Scopus
  15. M. M. Amoli, P. Amiri, M. Namakchian et al., “Adenosine deaminase gene polymorphism is associated with obesity in Iranian population,” Obesity Research and Clinical Practice, vol. 1, no. 3, pp. 173–177, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Espinal, R. A. John Challiss, and E. A. Newsholme, “Effect of adenosine deaminase and an adenosine analogue on insulin sensitivity in soleus muscle of the rat,” FEBS Letters, vol. 158, no. 1, pp. 103–106, 1983. View at Publisher · View at Google Scholar · View at Scopus
  17. M. P. McLane, P. R. Black, W. R. Law, and R. M. Raymond, “Adenosine reversal of in vivo hepatic responsiveness to insulin,” Diabetes, vol. 39, no. 1, pp. 62–69, 1990. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Hoshino, K. Yamada, K. Masuoka et al., “Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 25, no. 2, pp. 97–102, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. S. M. Johansson, E. Lindgren, J.-N. Yang, A. W. Herling, and B. B. Fredholm, “Adenosine A1 receptors regulate lipolysis and lipogenesis in mouse adipose tissue—interactions with insulin,” European Journal of Pharmacology, vol. 597, no. 1–3, pp. 92–101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. J. Vannucci, H. Nishimura, S. Satoh, S. W. Cushman, G. D. Holman, and I. A. Simpson, “Cell surface accessibility of GLUT4 glucose transporters in insulin-stimulated rat adipose cells. Modulation by isoprenaline and adenosine,” Biochemical Journal, vol. 288, no. 1, pp. 325–330, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Takasuga, T. Katada, M. Ui, and O. Hazeki, “Enhancement by adenosine of insulin-induced activation of phosphoinositide 3-kinase and protein kinase B in rat adipocytes,” The Journal of Biological Chemistry, vol. 274, no. 28, pp. 19545–19550, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. A. C. Warrier, N. Y. Rao, D. S. Kulpati, T. K. Mishra, and B. C. Kabi, “Evaluation of adenosine deaminase activity and lipid peroxidation levels in diabetes mellitus,” Indian Journal of Clinical Biochemistry, vol. 10, no. 1, pp. 9–13, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. J. C. Pickup and M. A. Crook, “Is type II diabetes mellitus a disease of the innate immune system?” Diabetologia, vol. 41, no. 10, pp. 1241–1248, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Morohoshi, K. Fujisawa, I. Uchimura, and F. Numano, “Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro,” Diabetes, vol. 45, no. 3, pp. 954–959, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. J. C. Pickup, “Inflammation and activated innate immunity in the pathogenesis of type 2 diabletes,” Diabetes Care, vol. 27, no. 3, pp. 813–823, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. O. J. Cordero, F. J. Salgado, C. M. Fernández-Alonso et al., “Cytokines regulate membrane adenosine deaminase on human activated lymphocytes,” Journal of Leukocyte Biology, vol. 70, no. 6, pp. 920–930, 2001. View at Google Scholar · View at Scopus
  27. M. Mokhtari, M. Hashemi, M. Yaghmaei et al., “Serum adenosine deaminase activity in gestational diabetes mellitus and normal pregnancy,” Archives of Gynecology and Obstetrics, vol. 281, no. 4, pp. 623–626, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Stentz and A. E. Kitabchi, “Activated T lymphocytes in type 2 diabetes: implications from in vitro studies,” Current Drug Targets, vol. 4, no. 6, pp. 493–503, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Kumar and A. Sharma, “Adenosine: an endogenous modulator of innate immune system with therapeutic potential,” European Journal of Pharmacology, vol. 616, no. 1–3, pp. 7–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Dolzal, “Adenosine deaminase. Review of physiological roles,” 2001, http://www.entu.cas.cz/fyziol/seminars/ada/html.
  31. M. Sakowicz-Burkiewicz, K. Kocbuch, M. Grden, A. Szutowicz, and T. Pawelczyk, “Diabetes-induced decrease of adenosine kinase expression impairs the proliferation potential of diabetic rat T lymphocytes,” Immunology, vol. 118, no. 3, pp. 402–412, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Pawelczyk, M. Sakowicz, M. Szczepanska-Konkel, and S. Angielski, “Decreased expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats,” Archives of Biochemistry and Biophysics, vol. 375, no. 1, pp. 1–6, 1999. View at Publisher · View at Google Scholar
  33. T. Pawelczyk, M. Grden, R. Rzepko, M. Sakowicz, and A. Szutowicz, “Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat,” The American Journal of Pathology, vol. 167, no. 2, pp. 315–325, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Sakowicz, A. Szutowicz, and T. Pawelczyk, “Insulin and glucose induced changes in expression level of nucleoside transporters and adenosine transport in rat T lymphocytes,” Biochemical Pharmacology, vol. 68, no. 7, pp. 1309–1320, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Xu, D. A. Berkich, G. H. Crist, and K. F. LaNoue, “A1 adenosine receptor antagonism improves glucose tolerance in Zucker rats,” The American Journal of Physiology, vol. 274, no. 2, part 1, pp. E271–E279, 1998. View at Google Scholar
  36. S. E. Mills, “Regulation of porcine adipocyte metabolism by insulin and adenosine,” Journal of Animal Science, vol. 77, no. 12, pp. 3201–3207, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Kurtul, S. Pence, E. Akarsu, H. Kocoglu, and Y. Aksoy, “Adenosine deaminase activity in the serum of type 2 diabetic,” Acta Medica, vol. 47, pp. 33–35, 2004. View at Google Scholar
  38. T. Pawelczyk, M. Podgorska, and M. Sakowicz, “The effect of insulin on expression level of nucleoside transporters in diabetic rats,” Molecular Pharmacology, vol. 63, no. 1, pp. 81–88, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Fan, F. L. Tansi, W. A. Weihofen et al., “Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator,” European Journal of Cell Biology, vol. 91, no. 4, pp. 265–273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Ginés, M. Mariño, J. Mallol et al., “Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction,” Biochemical Journal, vol. 361, no. 2, pp. 203–209, 2002. View at Publisher · View at Google Scholar · View at Scopus